Pacific Dm syrup 120ml

Pacific DM Syrup contains the active ingredient Lamivudine, which belongs to the class of medications known as nucleoside reverse transcriptase inhibitors (NRTIs). It is formulated as an oral syrup for the treatment of HIV infection and chronic hepatitis B virus (HBV) infection.

Active Ingredient:

Lamivudine: This medication works by inhibiting the activity of reverse transcriptase, an enzyme necessary for the replication of HIV and HBV. By interfering with viral replication, Lamivudine helps to reduce the viral load and slow down the progression of the infections.

Uses:

Pacific DM Syrup is indicated for:

• Treatment of HIV-1 infection in combination with other antiretroviral agents.
• Treatment of chronic hepatitis B virus (HBV) infection in adults and pediatric patients.

Mechanism of Action:

Lamivudine inhibits the activity of reverse transcriptase, an enzyme responsible for converting viral RNA into DNA, which is essential for the replication of HIV and HBV. By blocking this process, Lamivudine prevents the formation of new viral particles and reduces viral replication.

Administration:

Take Pacific DM Syrup orally, as directed by a healthcare professional. The dosage and duration of treatment will depend on individual patient factors, such as the stage of infection and previous treatment history. Use a measuring device to ensure accurate dosing.

Side Effects:

Common side effects of Pacific DM Syrup may include:

• Headache
• Nausea or vomiting
• Diarrhea
• Fatigue or weakness
• Insomnia
• Rash or itching

Precautions:

• Inform your healthcare provider about any history of kidney disease, liver disease, or other medical conditions before starting Lamivudine.
• Monitor liver function tests regularly during treatment, especially in patients with hepatitis B infection.
• Lamivudine may cause lactic acidosis, a serious metabolic complication, particularly in patients with advanced HIV disease or liver disease.

When Not to Use:

Pacific DM Syrup is contraindicated in patients who are hypersensitive to Lamivudine or any components of the syrup. It should not be used as monotherapy for HIV infection or HBV infection.